Pharmacokinetic/Pharmacodynamic Modeling of the Effects of Intravenous Immunoglobulin on the Disposition of Antiplatelet Antibodies in a Rat Model of Immune Thrombocytopenia
- 1 June 2003
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 92 (6) , 1206-1215
- https://doi.org/10.1002/jps.10364
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Effects of intravenous immunoglobulin on platelet count and antiplatelet antibody disposition in a rat model of immune thrombocytopeniaBlood, 2002
- Anti-inflammatory Activity of IVIG Mediated Through the Inhibitory Fc ReceptorScience, 2001
- Immune thrombocytopenia and Fc receptor-mediated phagocyte functionAnnals of Hematology, 1994
- Autoantibodies against platelet glycoproteins in autoimmune thrombocytopenic purpura: their clinical significance and response to treatmentBlood, 1993
- Autoantibodies to the presumptive cytoplasmic domain of platelet glycoprotein IIIa in patients with chronic immune thrombocytopenic purpura [published erratum appears in Blood 1991 Dec 1;78(11):3109]Blood, 1991
- Inhibition of autoantibody binding to platelet glycoprotein IIb/IIIa by anti-idiotypic antibodies in intravenous gammaglobulinBlood, 1989
- High-dose intravenous immunoglobulin modifies complement-mediated in vivo clearanceBlood, 1989
- Transient Reversal of Thrombocytopenia in Idiopathic Thrombocytopenic Purpura by High-Dose Intravenous Gamma GlobulinNew England Journal of Medicine, 1982
- HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOODThe Lancet, 1981
- A Theoretical Model of γ-Globulin CatabolismNature, 1964